LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 40.14 | 84.90 | 2235 | 3682 | 0.6070 | 0.8246 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 40.14 | 84.90 | 246 | 3682 | 0.0668 | 0.2161 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 40.14 | 84.90 | 2029 | 3682 | 0.5511 | 0.7924 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 130 | 4003 | 0.0325 | 0.0797 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 2124 | 4003 | 0.5306 | 0.7845 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 2224 | 4003 | 0.5556 | 0.7993 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 2245 | 4003 | 0.5608 | 0.8024 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 293 | 4003 | 0.0732 | 0.2496 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 41.84 | 84.90 | 2227 | 4003 | 0.5563 | 0.7998 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 146 | 4287 | 0.0340 | 0.1006 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 2246 | 4287 | 0.5238 | 0.7840 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 2294 | 4287 | 0.5350 | 0.7907 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 2316 | 4287 | 0.5401 | 0.7937 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 318 | 4287 | 0.0742 | 0.2629 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 43.55 | 84.90 | 2232 | 4287 | 0.5205 | 0.7820 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 159 | 4539 | 0.0350 | 0.1155 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 2354 | 4539 | 0.5185 | 0.7838 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 2501 | 4539 | 0.5509 | 0.8027 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 2517 | 4539 | 0.5544 | 0.8047 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 346 | 4539 | 0.0762 | 0.2773 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 45.25 | 84.90 | 2329 | 4539 | 0.5130 | 0.7805 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 46.95 | 84.90 | 191 | 4952 | 0.0386 | 0.1482 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 46.95 | 84.90 | 2483 | 4952 | 0.5014 | 0.7779 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 46.95 | 84.90 | 2664 | 4952 | 0.5379 | 0.7994 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 46.95 | 84.90 | 2681 | 4952 | 0.5413 | 0.8013 | MN20160318_Q02 | K07 |